Q1 2025

Filed May 15, 2025 · 10-Q · 45 days after period end · 0001477932-25-003835

Q1 2025 · 10-Q

Revenue

$0.00

−100.0% vs Q1 2024

Net Income

-$427.00

N/M vs Q1 2024

EPS Diluted

-$0.01

N/M vs Q1 2024

Gross Profit$0−100.0%

Operating Income

Same quarter

Metric	Q1 2025	Q1 2024	Q1 2023	Q1 2022
Revenue	$0.00	$6.00K	$22.00K	$5.00K
Net Income	-$427.00	-$402.00K	-$869.00K	-$507.00K
EPS Diluted	-$0.01	-$0.01	-$0.02	-$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR